The relationship between TLR7 levels and sex-based differences in the clinical course of SARS-CoV-2 infection has been also demonstrated in studies featuring male patients with deleterious variants of TLR7 (Xp22.2) (167) leading to compromised TLR7 activation and severe COVID-19 (168). This evidence concerns the gene TLR7 and COVID-19.